Back to Search
PAUL NADLER, MD
MD
Internal Medicine Physician
NPI: 1336193663IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G74653(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Class of 1991
Research & Publications (4)
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
PMID 17149608·Cancer Chemother Pharmacol·2007
3-trial
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.
PMID 17189413·Clin Cancer Res·2006
3-trial
An interactive computer kiosk module for the treatment of recurrent uncomplicated cystitis in women.
PMID 16879705·J Gen Intern Med·2006
4-observational
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
PMID 15498605·Antiviral Res·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 PARNASSUS AVE
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2138
Quick Facts
- NPI
- 1336193663
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 4
Are you this provider?
Claim Your Profile